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Abstract
Background: Xanthine oxidoreductase has been proposed to play a role in the development of local and systemic
effects of acute pancreatitis. Under physiologic conditions, the enzyme exists mainly as xanthine dehydrogenase (XDH)
but can be converted by proteolytic cleavage to its superoxide-generating form xanthine oxidase (XOD). In addition to
its intracellular location XDH/XOD is also associated to the polysaccharide chains of proteoglycans on the external
endothelial cell membrane.
In the early stages of acute pancreatitis, this enzyme seems to be arising from its mobilization from the gastrointestinal
endothelial cell surface. Taking into account the ability of α-amylase to hydrolyze the internal α-1,4 linkages of
polysaccharides, we wanted to elucidate the involvement of α-amylase in XDH/XOD mobilization from the
gastrointestinal endothelial cell surface and the relevance of the ascitic fluid (AF) as the source of α-amylase in
experimental acute pancreatitis.
Methods: Acute pancreatitis was induced in male Wistar rats by intraductal administration of 5% sodium taurocholate.
In another experimental group 3000 U/Kg α-amylase was i.v. administered. The concentrations of XDH, XOD and α-
amylase in plasma and AF and myeloperoxidase (MPO) in lung have been evaluated. In additional experiments, the effect
of peritoneal lavage and the absorption of α-amylase present in the AF by an isolated intestine have been determined.
Results: Similar increase in XDH+XOD activity in plasma was observed after induction of acute pancreatitis and after
i.v. administration of α-amylase. Nevertheless, the conversion from XDH to XOD was only observed in the pancreatitis
group. Lung inflammation measured as MPO activity was observed only in the pancreatitis group. In addition peritoneal
lavage prevented the increase in α-amylase and XDH+XOD in plasma after induction of pancreatitis. Finally, it was
observed that α-amylase is absorbed from the AF by the intestine.
Conclusions: During the early stages of acute pancreatitis, α-amylase absorbed from AF through the gastrointestinal
tract could interfere with the binding of XDH/XOD attached to glycoproteins of the endothelial cells. Proteolytic
enzymes convert XDH into its oxidase form promoting an increase in circulating XOD that has been reported to be one
of the mechanisms involved in the triggering of the systemic inflammatory process.
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Background
Xanthine oxidoreductase has been reported to be one of
the most important sources of oxygen free radicals in dif-
ferent pathologies [1]. This enzyme catalyzes the final two
steps of the purine degradation pathway: oxidation of
hypoxanthine and xanthine to xanthine and uric acid,
respectively. Under physiologic conditions, the enzyme
exists mainly as xanthine dehydrogenase (XDH), a form
that uses NAD+ as electron acceptor. Nevertheless, under
certain circumstances, XDH can be converted to xanthine
oxidase (XOD) by limited proteolytic cleavage. XOD uses
molecular oxygen as electron acceptor and consequently
generates the superoxide anion [2], a molecule that partic-
ipates in the generation of other reactive oxygen species
including hydrogen peroxide, hydroxyl radical and
peroxynitrite.
This enzyme has been proposed to play a role in the devel-
opment of both local and systemic effects of acute pancre-
atitis [3-6], an inflammatory process of the pancreatic
gland. In experimental models of acute pancreatitis the
conversion of XDH to XOD by the action of proteolytic
enzymes has been reported [7]. Also, circulating XOD
seems to be a source of systemic oxidative stress [6]. This
is of importance since the systemic effects of pancreatitis,
in particular pulmonary dysfunction characterized by an
inflammatory infiltration of the lung parenchyma, are
observed in as many as 50% of patients. Severe forms of
pancreatitis progresses in two phases. In the first week the
main cause of death is the systemic inflammatory
response syndrome while in the second phase, sepsis-
related complications are the main cause of death. Respi-
ratory dysfunction in acute pancreatitis is usually mild
and reversible, but in the severe forms of the disease lung
injury could be progressive leading to an adult respiratory
distress syndrome. This fact appears to be one the most
important factors contributing to death in patients with
acute pancreatitis during the first week of the disease [8].
In vitro experiments have shown that in addition to its
intracellular location XDH/XOD is also associated to the
external endothelial cell membrane [9]. Other experi-
ments revealed that the addition of heparin inhibits the
binding of the enzyme to endothelial cells suggesting that
XDH/XOD binds to the polysaccharide chains of heparin-
like proteoglycans on the endothelial-cell plasma mem-
brane [10]. The binding is apparently of an electrostatic
nature: negatively charged groups presumably might
interact with some clusters of positively charged amino
acid residues of XDH/XOD [9]. This is an important fact
because during acute pancreatitis circulating XOD seems
to be arising from its mobilization from the surface of
endothelial cells [11] and not released by the pancreatic
tissue. It was noteworthy that during pancreatitis XDH/
XOD is mobilized only from the gastrointestinal system
[11].
Amongst the various factors released during acute pancre-
atitis, α-amylase could be suspected to be involved in the
mobilization of XDH/XOD attached to glycoproteins of
the endothelial cells. This is related to the ability of α-
amylase to hydrolyze the internal α-1,4 linkages of
polysaccharides that could affect some glycoproteins
present in the extracellular space and disrupt the binding-
site of XDH/XOD. Moreover, in vitro experiments demon-
strate that α-amylase bind to glycoproteins by carbohy-
drate-specific interaction, in particular with glycoproteins
possessing N-glycans [12]. Enzymatic activity or carbohy-
drate-specific interaction could explain the displacement
of XDH/XOD from the glycoprotein binding sites
observed during the early stages of acute pancreatitis. On
the other hand, transperitoneal absorption from ascitic
fluid (AF) is one of the pathways by way of which the
products released by damaged pancreas gain access to the
systemic circulation. Consequently, the local concentra-
tion of α-amylase could be greater in the gastrointestinal
tract than in the other organs. This could explain the fact
that during pancreatitis XDH/XOD is mobilized only
from the gastrointestinal tract.
Therefore, in the present work, we wanted to elucidate in
an experimental model of acute pancreatitis: 1) the
involvement of α-amylase in XDH/XOD mobilization
from the gastrointestinal endothelial cell surface and 2)
the relevance of the AF as the source of α-amylase in this
process.
Methods
General
Animals
Male Wistar rats (250–300 g b.w.) were used in all exper-
iments. Animals were housed in a controlled environ-
ment and fed with standard laboratory pelleted formula
(A04, Panlab, Barcelona, Spain) and tap water ad libitum.
This study conformed to European Community (Directive
86/609/EEC) for the use of experimental animals and the
institutional committee of animal care and research
approved it.
Pancreatitis
Animals were anesthetized with an i.p. administration of
10% urethane (1 ml/100 g b.w.). The biliopancreatic duct
was cannulated through the duodenum and the hepatic
duct was closed by a small bulldog clamp. Pancreatitis was
induced by retrograde perfusion into the biliopancreatic
duct of 5% sodium taurocholate (Sigma, St Louis, Mis-
souri, USA) in a volume of 0.1 ml/100 g b.w. using a per-
fusion pump (Harvard Instruments, Edenbridge, UK), 0.3
ml/min [13]. Control animals received an intraductalBMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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perfusion of saline solution (NaCl 0.9%). We have previ-
ously reported that, in this model, a significant neutrophil
infiltration occurs in the lung 3 h after the induction of
pancreatitis [6]. Therefore this was the time point chosen
for all experiments.
Experimental Design
Effect of α-Amylase in XDH/XOD mobilization from endothelial cells
In the first experiment we evaluated the ability of α-amy-
lase to mobilize XDH/XOD from endothelial cells as it
occurs during acute pancreatitis. For this purpose we have
set up the experimental groups:
• Controls (C): Intraductal infusion of saline solution (n =
6).
• Experimental acute pancreatitis (EAP): Intraductal infu-
sion of 5% sodium taurocholate (n = 6).
• α-Amylase (A): Animals were treated with 3000 U/kg α-
amylase (Roche, Basel, Switzerland) given as an intrave-
nous bolus immediately before an intraductal infusion of
saline solution. Previously α-amylase was purified by
Sephadex G-25 chromatography in order to remove
ammonium sulfate present in the buffer.
• Heat-denatured α-amylase (DA): In order to determine
the specificity of α-amylase, animals were treated with
heat-denatured  α-amylase before the intraductal per-
fusion of saline solution (n = 6). In this case, the enzyme
was previously heated during 60 min at 100°C. In these
conditions, the residual enzymatic activity observed was
less than 1%.
Plasma and lung tissue samples were obtained 3 h after
the intraductal infusion, immediately frozen and main-
tained at -80°C until XOD, XDH and α-amylase were
measured in plasma and myeloperoxidase (MPO) was
measured in lung.
Role of AF and effect of peritoneal lavage in XDH/XOD and α-
amylase activity in plasma and in lung inflammation
In a second experiment we have evaluated the hypothesis
that AF is the source of α-amylase involved in liberating
XDH/XOD from the gastrointestinal tract. For this pur-
pose, the following experimental groups were established:
• Controls (C): Intraductal infusion of saline solution (n =
6).
• Experimental acute pancreatitis (EAP): Intraductal infu-
sion of 5% sodium taurocholate (n = 6).
•  Experimental acute pancreatitis + peritoneal lavage
(EAP+PL): Intraductal perfusion of 5% sodium taurocho-
late (n = 6). In addition, a polyethylene catheter PE-10
(Clay-Adams, UK) was placed into the peritoneal cavity
and 60 ml of warm (37°C) sterile saline solution was
infused at a constant flow (20 ml/h) immediately after
induction of pancreatitis.
Plasma samples were obtained 0, 0.5, 1 and 3 h after the
intraductal perfusion of taurocholate. AF and lung tissue
samples were obtained 3 h after the induction of pancrea-
titis, immediately frozen and maintained at -80°C
Intestinal absorption of α-amylase
To evaluate the capacity of the intestinal tract on α-amy-
lase absorption from the AF we designed an ex vivo exper-
iment incubating an isolated rat intestine with AF
collected from pancreatitis animals 3 h after the intraduc-
tal perfusion of taurocholate. The concentration of amy-
lase released in the vascular perfusate was measured up to
1 h.
Small bowel was isolated as previously described [14].
Briefly, the abdomen was opened and the colon was iso-
lated and removed after ligation of the right and middle
colic vessels. The portal vascular pedicle was prepared by
transecting all pancreatic, gastric and splenic vessels. The
superior mesenteric artery was exposed, cannulated with
PE-50 tubing (Clay-Adams, UK) and immediately per-
fused with 5 ml of saline solution at 4°C. The portal vein
was cannulated with another PE-150 tubing (Clay-Adams,
UK), and the small bowel was free from the retroperito-
neal tissue. The apertures of the intestinal lumen were
closed with a ligature and the small bowel was placed in a
recipient containing 25 ml of saline solution at 4°C and
brought to the perfusion system.
Perfusion system
Cannulated small bowel was placed into a recipient with
15 ml of saline solution kept at 37°C. The mesenteric
artery was perfused with a modified Krebs-Henseleit
buffer containing 200 mg/dl of glucose at a maximum
pressure of 100 mm Hg. The perfusate was kept at 37°C
and oxygenated with 95% O2 and 5% CO2 during all the
perfusion period. The specimen was maintained during
10 min in these conditions. Then, saline solution was
replaced for 15 ml of AF and the vascular perfusion con-
tinued during 60 min. Samples were obtained at 1, 2, 3, 4,
5, 10, 30 and 60 min of the perfusion period.
Biochemical determinations
α-Amylase assay
α-Amylase was determined using commercial kits from
Sigma, (St Louis, Missouri, USA) according to the sup-
plier's specifications.BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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MPO assay
Measured photometrically employing 3,3',5,5'-tetrameth-
ylbenzidine as a substrate [15].
XDH and XOD activity
XOD and XDH activity were measured fluorometrically at
37°C via oxidation of pterin to isoxanthopterin, using
methylene blue as an electron acceptor [16].
Statistical analysis
Data have been expressed as mean ± SEM. Means of differ-
ent groups were compared using a one-way analysis of
variance. Student's t test was performed for evaluation of
significant differences between groups. Differences were
assumed to be significant when p < 0.05.
Results
Effect of α-Amylase in XDH/XOD mobilization from 
endothelial cells
Figure 1 shows the effect of acute pancreatitis or α-amy-
lase administration on plasma α-amylase, MPO, XDH
and XOD concentration. In our experimental conditions,
after α-amylase administration the level of XDH+XOD in
plasma was similar to that observed during acute pancre-
atitis (Figure 1a). As expected, denatured α-amylase-
treated animals showed no significant increase in plasma
α-amylase activity.
Amylase in plasma (a), XDH+XOD in plasma (b), MPO in lung (c) and % XOD in plasma (d) after induction of EAP or adminis- tration of α-amylase (A) or heat-denatured α-amylase (DA) Figure 1
Amylase in plasma (a), XDH+XOD in plasma (b), MPO in lung (c) and % XOD in plasma (d) after induction of EAP or adminis-
tration of α-amylase (A) or heat-denatured α-amylase (DA). α-Amylase induces an increase in the concentration of 
XDH+XOD similar to that observed during pancreatitis. Nevertheless conversion from XDH to XOD and increased MPO 
activity in the lung was only observed in the pancreatitis group. * = p < 0.05 vs control;BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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Increased levels of both XDH and XOD activity were
observed in pancreatitis group. In the case of α-amylase
administration a similar increase in XDH activity was
observed but, in the case of XOD, the increase was of
lesser magnitude than in pancreatitis (Figure 1b). No
change in XDH or XOD activity was found when the α-
amylase administered was heat-denatured. The reduced
increase in XOD activity in the α-amylase-treated animals
is explained by the fact that in the absence of pancreatitis
there is no conversion from the dehydrogenase to the oxi-
dase form. This could be clearly observed when the level
of XOD was expressed as percentage of the total
XDH+XOD activity (figure 1d).
α-Amylase per se is not enough to induce lung inflamma-
tion, as could be observed in figure 1c. Despite obtaining
equivalent concentrations of α-amylase in plasma after α-
amylase administration (Figure 1a), neutrophil infiltra-
tion, measured as MPO activity was not modified in the
lung. Although α-amylase induces an increase in the con-
centration of circulating XDH plus XOD similar to that
observed during acute pancreatitis (Figure 1b), the con-
version from XDH to XOD was only observed in the pan-
creatitis group (Figure 1d). In the control group, the
percentage of XOD was about 10% of the total enzyme.
This percentage increases to 40% in pancreatitis, when the
proteolytic activity of plasma was higher. In the amylase-
treated group, the percentage of XOD was not signifi-
cantly modified with respect to the control group.
XDH+XOD and α-amylase in plasma and AF
Figure 2 shows the kinetics of α-amylase and XDH+XOD
in plasma, and the final concentration achieved in AF 3 h
after induction of pancreatitis.
As expected, α-amylase levels in plasma showed progres-
sive increase after induction of EAP. Total XDH+XOD
activity in plasma also increases and achieves significant
levels 3 h after induction of pancreatitis. Finally, the con-
version of XDH to XOD also occurs in a time dependent
manner during pancreatitis. Interestingly, final α-amylase
concentration in AF was over 5 times greater that observed
in plasma. In contrast, similar concentrations of XOD and
XDH were observed both in plasma and AF at the same
time point.
Effect of peritoneal lavage in XDH/XOD and α-amylase 
activity in plasma and in lung inflammation
The increase of total XDH+XOD activity in plasma was
prevented when peritoneal lavage was carried out (Figure
3a). Nevertheless, peritoneal lavage did not prevent the
XDH to XOD conversion. Peritoneal lavage also prevented
the increase of α-amylase observed in plasma after the
induction of acute pancreatitis (figure 3b). Finally, the
increase in MPO activity in the lung observed after the
induction of pancreatitis was also prevented by peritoneal
lavage (Figure 3c).
XOD and XDH concentrations (a) and α-amylase (b) in  plasma and AF after the induction of pancreatitis Figure 2
XOD and XDH concentrations (a) and α-amylase (b) in 
plasma and AF after the induction of pancreatitis. Samples of 
plasma were obtained at 0, 0.5, 1 and 3 h after induction of 
pancreatitis. Concentration in AF was evaluated 3 h after the 
intraductal infusion of taurocholate. * = p < 0.05 vs time = 0.BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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Intestinal absorption of α-amylase
Figure 4 depicts the concentration of α-amylase measured
in the vascular perfusate at the output of the isolated intes-
tine when incubated in AF. α-Amylase was undetectable
when the intestine was incubated in saline solution (data
not shown). When intestine was incubated in AF α-amy-
lase in the vascular perfusate showed a rapid increase,
which achieved a maximal concentration in 10 min and
was maintained until the end of the experiment (60 min).
Discussion
The involvement of XOD-derived oxygen free radicals in
the pathogenesis of acute pancreatitis has been extensively
reported [3-5]. In pancreas, conversion of XDH to the free
radical-generating form XOD occurs during pancreatitis
and is due to the intrapancreatic proteolytic activity. In
addition, total XDH+XOD activity in plasma increases sig-
nificantly after the induction of pancreatitis. In the early
stages of acute pancreatitis, circulating XOD may act at
distant organs generating the superoxide radical species
that promote P-selectin expression and recruitment of
neutrophils [6]. Pulmonary endothelial cells seem to be
particularly sensitive, since systemic XOD-induced P-
selectin up-regulation was detected only in the lung [17].
This sensitivity could be also related with the environ-
ment generated by the disease, with high concentrations
of circulating cytokines, activation of complement system
and other potentially deleterious mechanisms operating.
It could be suspected that, as it occurs with other enzymes,
the increased XDH+XOD activity observed in plasma dur-
ing pancreatitis is related with the release of this enzyme
from pancreatic tissue. Nevertheless, in physiological con-
ditions, XDH/XOD is also bound to the polysaccharide
chains of heparin-like proteoglycans existing on the exter-
nal surface of the endothelial cells [9,10]. We have
recently reported that during pancreatitis the increase of
XDH/XOD observed in plasma is related with the mobili-
zation of the XDH/XOD enzyme bound to the surface of
the endothelial cells, in particular, from the endothelial
cells of the gastrointestinal tract [11].
Serum α-amylase is one of the most frequently used tests
for the diagnosis of acute pancreatitis [18]. Amongst the
Effect of peritoneal lavage (PL) in XDH+XOD (a) and α-amylase (b) plasma levels, and in MPO activity (c) in lung Figure 3
Effect of peritoneal lavage (PL) in XDH+XOD (a) and α-amylase (b) plasma levels, and in MPO activity (c) in lung. Peritoneal 
lavage prevents the increase found in α-amylase, MPO and total XDH+XOD, but does not affect the increase in the % of XOD 
observed during EAP. * = p < 0.05 vs control; + = p < 0.05 vs pancreatitis.
α-Amylase absorption from isolated perfused intestine incu- bated with AF obtained from animals with pancreatitis Figure 4
α-Amylase absorption from isolated perfused intestine incu-
bated with AF obtained from animals with pancreatitis. Sam-
ples of the perfusion buffer were obtained after placing the 
organ in the AF t = 0. Maximal concentration was achieved 
10 min after the initiation of the incubation and maintained 
for 1 h. * = p < 0.05 vs. time = 1 min.BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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various factors released during acute pancreatitis, α-amy-
lase could be involved in the mobilization of XDH/XOD
attached to glycoproteins of the endothelial cells. This is
related to the ability of α-amylase to hydrolyze the inter-
nal  α-1,4 linkages of polysaccharides that could affect
some glycoproteins and disrupt the binding-site of XDH/
XOD. On the other hand, in vitro experiments demon-
strated that α-amylase binds by carbohydrate-specific
interaction to glycoproteins possesing N-glycans [12].
Thus, the enzyme could also displace XDH/XOD through
competition for the binding site.
To evaluate this possibility, we administered an amount
of α-amylase tailored to induce a final concentration in
plasma similar to that observed in experimental pancrea-
titis. In this condition, we observed an increase in
XOD+XDH concentration in plasma similar to that
observed during pancreatitis (Figure 1b).
The effect of α-amylase appears to be not due to unspecific
interactions since heat-denaturalized α-amylase failed to
induce the increase in XDH+XOD activity in plasma (Fig-
ure 1b). Nevertheless, the possibility that heat treatment
inhibits the glycoprotein binding site of α-amylase cannot
be excluded. In fact, there is no evidence in the literature
indicating the capability of α-amylase to hydrolize mem-
brane bound glycoprotein. On the other hand, it has been
reported that α-amylase is able to digest proteoglycogen
[19], indicating that this enzyme could act on protein-
bound polysaccharides.
In addition, α-amylase administration had effect only in
the mobilization of XDH/XOD but the enzyme remains
mainly in its dehydrogenase form. This form did not gen-
erate superoxide radicals, probably for this reason we
found that, despite the increase in total circulating
XDH+XOD, lung inflammation was observed only when
there was a significant increase in the oxidase form of the
enzyme (Figures 1c and 1d). The conversion occurs as a
consequence of proteolytic cleavage of the enzyme proba-
bly due to the activation of proteolytic enzymes and this
fact occurs only during pancreatitis. In fact, proteolytic
conversion to the oxidase form was only observed after
induction of pancreatitis (figure 1).
These results indicate that, effectively, the pancreatic α-
amylase released during acute pancreatitis interferes with
the binding of XDH/XOD to endothelial cells, thus con-
tributing to the increase observed in the plasma concen-
tration of this enzyme. The proteolytic activity associated
with the disease converts the enzyme to the superoxide-
generating form, contributing to the inflammation in the
lung through a free radical-dependent mechanism.
Nevertheless, during pancreatitis, mobilization of XDH/
XOD is restricted to the gastric and intestinal endothelial
surface [11]. To explain this fact we hypothesized that α-
amylase present in the AF could be important in this
regard. This fluid contains biologically active agents, such
as pancreatic lipase, phospholipase A2, α-amylase, pro-
teases, complement factors, kinins, and inflammatory
mediators, which are released into the peritoneal cavity
during acute pancreatitis [20]. Products released by pan-
creas gain access to the systemic circulation by different
pathways: transperitoneal absorption from AF, direct
transfer into veins draining the pancreas and absorption
into pancreatic and retroperitoneal lymphatics [21].
Local concentration of α-amylase absorbed from AF could
be greater in the gastrointestinal tract than in other
organs. When comparing the concentrations observed in
plasma and in the AF, we observed that the enzyme con-
centration is about five fold higher in AF (Figure 2). This
fact does not occur for XDH/XOD. Therefore, a high
absorption and local concentration of α-amylase in the
gastrointestinal vessels could be expected and
consequently, its effect on the XDH/XOD binding could
be most important in this organ.
To verify this possibility we performed a peritoneal lavage
in a group of animals, immediately after the induction of
pancreatitis (Figure 3). When AF was removed by the lav-
age, the increase in α-amylase activity in plasma was not
observed and the inflammatory process in the lung was
also prevented. With respect to the XDH/XOD, there was
no increase in total enzyme concentration. This fact agrees
with the hypothesis that α-amylase absorbed from the AF
is needed to mobilize XDH/XOD and that the proteolytic
conversion of the enzyme occurs through a different,
independent mechanism. On the other hand, peritoneal
lavage results in a reduction of XOD levels in plasma, but
the difference is not very high. By contrast, differences
observed in MPO levels in the lung as a consequence of
peritoneal lavage was highly significant. This fact suggests
that peritoneal lavage also removes other mediators
involved in the development of the lung inflammation
and pointed out the importance of the interactions
between different pro-inflammatory pathways in this
process. This consideration applies also to other mecha-
nisms suggested by these results. For example, the
observed conversion from XDH to XOD occurs by prote-
olytic cleavage but the particular proteolytic enzymes
involved in this conversion remains to be elucidated. In
addition, there are considerable interspecific differences
in the levels of both proteolytic activity and protease
inhibitors. Obviously, further studies are needed in
humans to verify the applicability of these results to
human disease.BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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The ability of the gastrointestinal tract to absorb α-amy-
lase from the AF was also directly assessed by incubating
an isolated intestine with AF obtained from animals with
pancreatitis and measuring the enzyme concentration in
the vascular perfusate (Figure 4). Results indicate that
enzyme absorption was fast and that the maximum value
was achieved only ten minutes after the incubation. By
contrast, XDH/XOD activity was not observed in the elu-
ate, discarding a significant intraperitoneal absorption of
this enzyme. This fact was not surprising since the concen-
tration of XDH/XOD in AF is not increased with respect to
that in plasma (Figure 2).
Peritoneal lavage has been suggested to be of therapeuti-
cal value in patients with acute pancreatitis. Some
experimental studies reported beneficial effects of this
method in reducing the systemic effects of pancreatitis,
but in general, experimental work started the lavage
immediately after the induction of pancreatitis [22]. In
clinical work, results are by far less clear and our results
could help to explain this fact [23]. Lavages are performed
in patients only after acute pancreatitis is diagnosed. Since
the increased α-amylase concentration is one of the usual
parameters for the diagnosis of acute pancreatitis, in the
clinical practice the lavage does not start until the α-amy-
Suggested mechanism of the mobilization of XDH/XOD from the surface of the endothelial cells of gastrointestinal tract during  acute pancreatitis: α-Amylase released from the pancreas acts on the polysaccharide chains of the endothelial cells and mobi- lizes the enzyme, mainly present as XDH Figure 5
Suggested mechanism of the mobilization of XDH/XOD from the surface of the endothelial cells of gastrointestinal tract during 
acute pancreatitis: α-Amylase released from the pancreas acts on the polysaccharide chains of the endothelial cells and mobi-
lizes the enzyme, mainly present as XDH. Proteolytic enzymes convert this enzyme into its oxidase form. In addition, acinar 
cells from the damaged pancreas release xanthine resulting from purine catabolism. Then, the simultaneous presence of xan-
thine and XOD in the bloodstream constitutes a circulating free radical-generating system that could induce the up regulation 
of cell adhesion molecules and the inflammatory response in the lungs.BMC Gastroenterology 2004, 4 http://www.biomedcentral.com/1471-230X/4/1
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lase concentration increases; too late to prevent the release
of XDH/XOD induced by α-amylase.
It is important to consider that α-amylase could enter the
systemic circulation through different pathways. In a pre-
vious work, using the same experimental model, we have
observed a similar involvement for lymphatic draining
and peritoneal absorption pathways [24]. Nevertheless,
results obtained in this work suggest that only the α-amy-
lase uptake by the splanchnic circulation is involved in the
mobilization of XDH/XOD from the gastrointestinal
endothelium.
In conclusion, our results indicate that during pancreati-
tis, α-amylase absorbed from AF in the gastrointestinal
tract interferes the binding of XDH/XOD attached to the
glycoproteins of the endothelial cells (Figure 5). The pro-
teolytic activity associated with the disease converts the
enzyme in the superoxide-generating form, inducing the
inflammation in the lung through a free radical-depend-
ent mechanism.
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